Onto Innovation reported second-quarter 2026 revenue of $343.1 million, up 35.3% from a year earlier, with GAAP diluted EPS of $1.21 versus $0.69 and non-GAAP diluted EPS of $1.93 versus $1.25. The company guided third-quarter 2026 revenue to $380 million to $400 million and non-GAAP diluted EPS to $2.18 to $2.38, both above the second-quarter levels, and said its backlog exceeded $1 billion for the first time.
Q2 2026 revenue of $343.1 million, up 35.3% from $253.6 million in Q2 2025; GAAP net income $60.1 million
Diluted EPS of $1.21 GAAP and $1.93 non-GAAP, versus $0.69 and $1.25 in Q2 2025
Q3 2026 outlook: revenue of $380 million to $400 million; GAAP diluted EPS of $1.54 to $1.70
Backlog exceeded $1 billion for the first time; cash and short-term investments were $1.88 billion at June 30, 2026
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Onto Innovation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2026
$1.01B
+1.8%
$2.78
-31.5%
13.6%
FY2024
$987.32M
+21.0%
$4.06
+65.0%
20.4%
FY2023
$815.87M
-18.8%
$2.46
-45.2%
14.9%
FY2022
$1.01B
+27.4%
$4.49
+57.0%
22.2%
FY2022
$788.90M
+41.8%
$2.86
+354.0%
18.0%
Frequently asked questions
When is Onto Innovation's next earnings date?
Onto Innovation (ONTO) is scheduled to report on Monday, November 09, 2026 after the market closes. Analysts expect EPS of $2.27.
What did Onto Innovation earn last quarter?
For the quarter ended Jun 2026, Onto Innovation reported diluted EPS of $1.21 (+75.4% year over year) on revenue of $343.13M (+35.3%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.